A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
about
Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targetingLithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.A potential strategy for high-grade gliomas: combination treatment with lithium chloride and BmK CT.Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Artemisinin and curcumin inhibit Drosophila brain tumor, prolong life span, and restore locomotor activity.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.
P2860
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@ast
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@en
type
label
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@ast
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@en
prefLabel
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@ast
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@en
P2093
P2860
P1433
P1476
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
@en
P2093
Daniel L Mulkerin
Herbert Chen
Kyle D Holen
Mary Ndiaye
Muthusamy Kunnimalaiyaan
Noelle K Loconte
Sam J Lubner
William R Schelman
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0323
P577
2011-03-10T00:00:00Z